← Insider buys

Christopher Lesovitz bought SSKN once, on May 12, 2022

CFO at STRATA Skin Sciences, Inc.

SEC CIK 0001887239 · Filings on SEC.gov ↗

$26KBought
$0Sold
May 13Last buy

Christopher Lesovitz's record

3 months after each buy, from the first price a copier could get.

1 buy has 3 months of prices so far. A record shows here at 3.

Every filing

1 filing since May 2022, newest first

About Christopher Lesovitz

Christopher (Chris) Lesovitz is a finance executive and certified public accountant who has served as Chief Financial Officer of STRATA Skin Sciences, Inc., a NASDAQ‑listed medical technology company focused on dermatologic treatments.( He was appointed CFO effective October 16, 2021, after previously serving as the company’s Controller and succeeding outgoing CFO Matthew Hill.( In this role, Lesovitz oversaw financial reporting, capital planning, and strategic finance initiatives, including supporting STRATA’s funding activities to strengthen its balance sheet and growth ambitions.(

Before joining STRATA Skin Sciences, Lesovitz led the finance organization at Encore Dermatology, Inc. as Head of Finance and Accounting, and earlier held multiple finance and accounting leadership positions at Iroko Pharmaceuticals, LLC, including Assistant Controller and Senior Accounting Manager.( He began his career in public accounting as a Senior Accountant with BDO USA, LLP, building expertise in financial reporting, controls, and analysis.( Lesovitz holds a Bachelor of Science in Accounting from Villanova University and is a Certified Public Accountant (CPA) in Pennsylvania, combining more than two decades of progressive experience in accounting and corporate finance with specialized focus in pharmaceuticals and dermatology.(

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.